# A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects

> **NCT01425463** · PHASE3 · COMPLETED · sponsor: **Sanol GmbH** · enrollment: 256 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Ferrous (II) Glycine Sulphate Complex
- **DRUG:** Polyferose
- **OTHER:** Placebo to Ferrous (II) Glycine Sulphate Complex
- **OTHER:** Placebo to Polyferose

## Key facts

- **NCT ID:** NCT01425463
- **Lead sponsor:** Sanol GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2015-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425463, "A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01425463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*